Cetera Advisor Networks’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $455K | Sell |
7,036
-2,025
| -22% | -$131K | ﹤0.01% | 1993 |
|
|
2023
Q4 | $597K | Sell |
9,061
-7,960
| -47% | -$524K | ﹤0.01% | 1732 |
|
|
2023
Q3 | $971K | Sell |
17,021
-867
| -5% | -$49.5K | 0.01% | 1304 |
|
|
2023
Q2 | $1.1M | Sell |
17,888
-725
| -4% | -$44.4K | 0.01% | 1207 |
|
|
2023
Q1 | $1.17M | Sell |
18,613
-885
| -5% | -$55.5K | 0.01% | 1140 |
|
|
2022
Q4 | $1.24M | Buy |
19,498
+140
| +0.7% | +$8.89K | 0.01% | 1061 |
|
|
2022
Q3 | $1.14M | Sell |
19,358
-1,037
| -5% | -$61.1K | 0.01% | 819 |
|
|
2022
Q2 | $1.18M | Sell |
20,395
-6,209
| -23% | -$359K | 0.02% | 806 |
|
|
2022
Q1 | $1.65M | Buy |
26,604
+5,019
| +23% | +$311K | 0.02% | 691 |
|
|
2021
Q4 | $1.54M | Buy |
+21,585
| New | +$1.54M | 0.02% | 706 |
|
|
2020
Q3 | – | Sell |
-1,994
| Closed | -$116K | – | 2483 |
|
|
2020
Q2 | $116K | Buy |
+1,994
| New | +$116K | ﹤0.01% | 1412 |
|
|
2016
Q2 | – | Sell |
-5,226
| Closed | -$204K | – | 857 |
|
|
2016
Q1 | $204K | Sell |
5,226
-428
| -8% | -$16.7K | 0.01% | 745 |
|
|
2015
Q4 | $283K | Sell |
5,654
-50
| -0.9% | -$2.5K | 0.02% | 626 |
|
|
2015
Q3 | $264K | Buy |
5,704
+374
| +7% | +$17.3K | 0.02% | 627 |
|
|
2015
Q2 | $297K | Hold |
5,330
| – | – | 0.02% | 627 |
|
|
2015
Q1 | $297K | Sell |
5,330
-1,451
| -21% | -$80.9K | 0.02% | 631 |
|
|
2014
Q4 | $339K | Sell |
6,781
-2,042
| -23% | -$102K | 0.02% | 558 |
|
|
2014
Q3 | $409K | Buy |
8,823
+1,302
| +17% | +$60.4K | 0.03% | 510 |
|
|
2014
Q2 | $327K | Sell |
7,521
-196
| -3% | -$8.52K | 0.02% | 593 |
|
|
2014
Q1 | $316K | Buy |
7,717
+2,240
| +41% | +$91.7K | 0.02% | 570 |
|
|
2013
Q4 | $201K | Sell |
5,477
-333
| -6% | -$12.2K | 0.02% | 694 |
|
|
2013
Q3 | $206K | Buy |
+5,810
| New | +$206K | 0.02% | 623 |
|